A Study in Rheumatoid Arthritis With an Investigational Oral p38 MAP Kinase Inhibitor VX-702

Mise à jour : Il y a 4 ans
Référence : NCT00395577

Femme et Homme

Extrait

The purpose of this study is to assess the safety and effects of VX-702 in subjects with moderate to severe rheumatoid arthritis and who are taking the drug methotrexate.


Critère d'inclusion

  • Rheumatoid Arthritis


Liens